RepliCel Life Sciences Inc.
REPCF
Price:
$0.0001
Market Cap:
$1.10M
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research p...[Read more]
Industry
Biotechnology
IPO Date
2010-05-03
Stock Exchange
OTC
Ticker
REPCF
PE Ratio
[-0.01]
ROE
[-3.25%]
Current Ratio
[0.03]
Dividend Yield
[0%]
Enterprise Value
[2.20M]
Dividend History
The PE Ratio as of December 2025 (TTM) for RepliCel Life Sciences Inc. (REPCF) is -0.01
According to RepliCel Life Sciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.64% compared to the average of -2.80 of the last 4 quarters.
RepliCel Life Sciences Inc. (REPCF) Historical PE Ratio (quarterly & annually)
How has REPCF PE Ratio performed in the past?
The mean historical PE Ratio of RepliCel Life Sciences Inc. over the last ten years is -4.61. The current -0.01 PE Ratio has changed -78.32% with respect to the historical average. Over the past ten years (40 quarters), REPCF's PE Ratio was at its highest in in the December 2024 quarter at 0.57. The PE Ratio was at its lowest in in the December 2020 quarter at -6.44.
Average
-4.61
Median
-2.89
Minimum
-12.80
Maximum
-1.30
RepliCel Life Sciences Inc. (REPCF) PE Ratio by Quarter and Year
Discovering the peaks and valleys of RepliCel Life Sciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 185.65%
Maximum Annual PE Ratio = -1.30
Minimum Annual Increase = -53.26%
Minimum Annual PE Ratio = -12.80
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -12.80 | 3.74% |
| 2023 | -12.34 | 185.65% |
| 2022 | -4.32 | 135.52% |
| 2021 | -1.83 | -53.26% |
| 2020 | -3.92 | 91.79% |
| 2019 | -2.05 | -29.54% |
| 2018 | -2.90 | 122.64% |
| 2017 | -1.30 | -26.24% |
| 2016 | -1.77 | -38.48% |
| 2015 | -2.88 | -20.64% |
RepliCel Life Sciences Inc. (REPCF) Average PE Ratio
How has REPCF PE Ratio performed in the past?
The current PE Ratio of RepliCel Life Sciences Inc. (REPCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.82
5-year avg
-7.05
10-year avg
-4.61
RepliCel Life Sciences Inc. (REPCF) PE Ratio vs. Peers
How is REPCF’s PE Ratio compared to its peers?
RepliCel Life Sciences Inc.’s PE Ratio is greater than ProtoKinetix, Incorporated (-6.69), greater than Acrux Limited (-1.08), greater than Sigyn Therapeutics, Inc. (-1.00), less than HAVN Life Sciences Inc. (-0.01), greater than Zelira Therapeutics Limited (-1.09), greater than Regen BioPharma, Inc. (-0.25), greater than AXIM Biotechnologies, Inc. (-2.12), greater than Mosaic ImmunoEngineering Inc. (-1.84), greater than Therma Bright Inc. (-60.81), greater than Restart Life Sciences Corp. (-2.72),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.69 | $1.96M | |
| -1.08 | $4.11M | |
| -1.00 | $3.21M | |
| -0.01 | $48.73K | |
| -1.09 | $2.38M | |
| -0.25 | $315.55K | |
| -2.12 | $7.33M | |
| -1.84 | $4.38M | |
| -60.81 | $2.61M | |
| -2.72 | $2.27M |
Build a custom stock screener for RepliCel Life Sciences Inc. (REPCF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RepliCel Life Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
RepliCel Life Sciences Inc. (REPCF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like RepliCel Life Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is RepliCel Life Sciences Inc.'s PE Ratio?
How is the PE Ratio calculated for RepliCel Life Sciences Inc. (REPCF)?
What is the highest PE Ratio for RepliCel Life Sciences Inc. (REPCF)?
What is the 3-year average PE Ratio for RepliCel Life Sciences Inc. (REPCF)?
What is the 5-year average PE Ratio for RepliCel Life Sciences Inc. (REPCF)?
How does the current PE Ratio for RepliCel Life Sciences Inc. (REPCF) compare to its historical average?